A DISTINCT SUBTYPE OF M4/M5 ACUTE MYELOBLASTIC-LEUKEMIA (AML) ASSOCIATED WITH T(8-16)(P11-P13), IN A PATIENT WITH THE VARIANT T(8-19)(P11-Q13) - CASE-REPORT AND REVIEW OF THE LITERATURE

被引:47
|
作者
STARK, B
RESNITZKY, P
JEISON, M
LURIA, D
BLAU, O
AVIGAD, S
SHAFT, D
KODMAN, Y
GOBUZOV, R
ASH, S
STEIN, J
YANIV, I
BARAK, Y
ZAIZOV, R
机构
[1] CHILDRENS MED CTR ISRAEL,IMMUNOPHENOTYPING LAB,PETAH TIQWA,ISRAEL
[2] CHILDRENS MED CTR ISRAEL,TUMOR MOLEC GENET LAB,PETAH TIQWA,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[4] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,KAPLAN HOSP,DEPT MED B,REHOVOT,ISRAEL
[5] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,KAPLAN HOSP,EFRATI RES INST BLOOD CELLS & CYTOL,REHOVOT,ISRAEL
关键词
ACUTE MYELOBLASTIC LEUKEMIA; M4; M5; SUBTYPES; KARYOTYPE; T(8P11-V) MORPHOCYTOCHEMISTRY; ULTRASTRUCTURE; PHENOTYPE;
D O I
10.1016/0145-2126(94)00150-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myeloblastic leukemia (AML) with t(8:16) or its variant t(8:V) has been rarely reported. A high proportion of patients are infants and children, often with a bleeding tendency and disseminated intravascular coagulopathy (DIC). Only one-third of the de novo patients remain in the first complete remission following multiagent chemotherapy and bone marrow transplantation (BMT). Morphocytochemically, the disorder is classified as an M5, M4, or M4/M5 variant. In the presented case, with the variant t(8:19)(p11:q13), comprehensive light and electron microscopic blast cell characterization showed monocytic and granulocytic features compatible with the M4 subtype (on the monocytic predominance range of the French-American-British classification scale). Although hemophagocytosis, one of the hallmarks of the disease, was rare in our patient, numerous autophagic vacuoles were present. Immuno- and genotyping showed a myelomonocytic phenotype with no evidence of early progenitor antigen expression or mixed leukemia. These results and those of previous reports support the high specificity of t(8:16) or its variants to the unique M4/M5 type leukemia and the role of a gene on 8p11 in this specific transformation.
引用
收藏
页码:367 / 379
页数:13
相关论文
共 50 条
  • [41] A new variant translocation of t(15;17) in a patient with acute promyelocytic leukemia (M3): t(15;19;17)(q22;p13;q12)
    Saitoh, K
    Miura, I
    Kobayashi, Y
    Kume, M
    Utsumi, S
    Takahashi, N
    Hatano, Y
    Nimura, T
    Hashimoto, K
    Takahashi, S
    Miura, AB
    CANCER GENETICS AND CYTOGENETICS, 1998, 102 (01) : 15 - 18
  • [42] Novel t(8;17)(q23;q24.2) and t(9;22)(p24.1;q12.2) in acute megakaryoblastic leukemia AML-M7 subtype in an adult patient
    Ahmad, Firoz
    Dalvi, Rupa
    Das, Bibhu Ranjan
    Mandava, Swarna
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (02) : 112 - 115
  • [43] ACUTE MYELO-MONOCYTIC LEUKEMIA (M4) WITH T(14-18) (Q11-P11.2), DEL(16) (Q22-QTER) AND CONSTITUTIONAL INV(9)
    DASTUGUE, N
    BOURROUILLOU, G
    COLOMBIES, P
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1985, 27 (02): : 77 - 77
  • [44] Translocation (11;19)(q23;p13.3) associated with a novel t(5;16) (ql3;q22) in a patient with acute myelocytic leukemia
    Vendrame-Goloni, CB
    Varella-Garcia, M
    Carvalho-Salles, AB
    Ruiz, MA
    Ricci, O
    Fett-Conte, AC
    CANCER GENETICS AND CYTOGENETICS, 2003, 141 (01) : 71 - 74
  • [45] Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2). (Retraction of vol 188, pg 95, 2009)
    Wang, H.
    Yang, W.
    Shao, H.
    Zhang, J.
    Li, Q.
    Liao, A.
    Li, Y.
    Liu, Z.
    CANCER GENETICS AND CYTOGENETICS, 2009, 192 (01) : 54 - 54
  • [46] B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare Case and Review of the Literature
    Trimaldi, Janese
    Carballido, Estrella M.
    Bowers, Jeremy W.
    Anguiano, Arturo L.
    Zhang, Zhong J.
    Shah, Bijal D.
    Bruno, Salvador
    List, Alan F.
    Moscinski, Lynn C.
    Grady, Terrence
    Agosti, Steven J.
    Kang, Loveleen
    Zhang, Ling
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 127 - 134
  • [47] Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation
    Suehiro, Y
    Uike, N
    Kumagawa, M
    Goto, T
    Muta, K
    Kozuru, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (03) : 165 - 166
  • [48] Gene expression signature of acute myeloid leukemia (AML) with T(8;16)(P11;P13) and MYST3-CREBBP rearrangement:: A microarray study validated by multiple real-time PCR.
    Camos, M
    Esteve, J
    Colomer, D
    Jares, P
    Rozman, M
    Villamor, N
    Costa, D
    Carrio, A
    Nomdedeu, JF
    Montserrat, E
    Campo, E
    BLOOD, 2005, 106 (11) : 843A - 843A
  • [49] A new cryptic ins(11;1)(q23;q21q31) detected in a t(1;8;11)(q21;p21;q23) in a baby with acute myeloid leukemia FAB AML-M5
    de Figueiredo, Amanda Faria
    Liehr, Thomas
    Bath, Samarth
    Binato, Renata
    Soares Ventura, Eliane Maria
    de Souza, Mariana Tavares
    Capela de Matos, Roberto Rodrigues
    Ribeiro, Raul Correa
    Abdelhay, Eliana
    Macedo Silva, Maria Luiza
    BLOOD CELLS MOLECULES AND DISEASES, 2010, 45 (03) : 197 - 198
  • [50] Acute Leukemia Showing t(8;22)(p11;q11), Myelodysplasia, CD13/CD33/CD19 Expression and Immunoglobulin Heavy Chain Gene Rearrangement
    Shimanuki, Masaya
    Sonoki, Takashi
    Hosoi, Hiroki
    Watanuki, Jyuri
    Murata, Shogo
    Mushino, Toshiki
    Kuriyama, Kodai
    Tamura, Shinobu
    Hatanaka, Kazuo
    Hanaoka, Nobuyoshi
    Nakakuma, Hideki
    ACTA HAEMATOLOGICA, 2013, 129 (04) : 238 - 242